Prostaglandin E receptor subtype 4 protects against diabetic cardiomyopathy by modulating cardiac fatty acid metabolism via FOXO1/CD36 signalling
Open Access
- 26 February 2021
- journal article
- research article
- Published by Elsevier BV in Biochemical and Biophysical Research Communications
- Vol. 548, 196-203
- https://doi.org/10.1016/j.bbrc.2021.01.038
Abstract
No abstract availableKeywords
Funding Information
- China Postdoctoral Science Foundation
- National Natural Science Foundation of China
- Bureau of Education of Guangzhou Municipality
This publication has 25 references indexed in Scilit:
- Cardiac-Specific Deletion of Acetyl CoA Carboxylase 2 Prevents Metabolic Remodeling During Pressure-Overload HypertrophyCirculation Research, 2012
- Metabolic stress–induced activation of FoxO1 triggers diabetic cardiomyopathy in miceJCI Insight, 2012
- Development of a Nongenetic Mouse Model of Type 2 DiabetesExperimental Diabetes Research, 2011
- FoxO Transcription Factors Promote Cardiomyocyte Survival upon Induction of Oxidative StressOnline Journal of Public Health Informatics, 2011
- Echocardiography in MiceCurrent Protocols in Mouse Biology, 2011
- Protein Kinase A-α Directly Phosphorylates FoxO1 in Vascular Endothelial Cells to Regulate Expression of Vascular Cellular Adhesion Molecule-1 mRNAOnline Journal of Public Health Informatics, 2011
- Diabetic cardiomyopathy, causes and effectsReviews in Endocrine and Metabolic Disorders, 2010
- FoxO1 Stimulates Fatty Acid Uptake and Oxidation in Muscle Cells through CD36-dependent and -independent MechanismsOnline Journal of Public Health Informatics, 2005
- Abnormal Angiogenesis in Foxo1 (Fkhr)-deficient MiceOnline Journal of Public Health Informatics, 2004
- Prostaglandin E 2 Protects the Heart From Ischemia-Reperfusion Injury via Its Receptor Subtype EP 4Journal of the American College of Cardiology, 2004